Subunit- and site-specific pharmacology of the NMDA receptor channel.
about
NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1An MCASE approach to the search of a cure for Parkinson's Disease.A brief history of the development of antidepressant drugs: from monoamines to glutamateCathepsin L plays a role in quinolinic acid-induced NF-Κb activation and excitotoxicity in rat striatal neuronsGlutamate receptor ion channels: structure, regulation, and functionDevelopmental and hormonal regulation of NR2A mRNA in forebrain regions controlling avian vocal learning.Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionMolecular targets for treating cognitive dysfunction in schizophrenia.The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathwaysN-methyl-D-aspartate receptor subunit phenotypes of vagal afferent neurons in nodose ganglia of the rat.Amygdalar glutamatergic neuronal systems play a key role on the hibernating state of hamsters.In vivo blockade of N-methyl-D-aspartate receptors induces rapid trafficking of NR2B subunits away from synapses and out of spines and terminals in adult cortex.Coincident glutamatergic and cholinergic inputs transiently depress glutamate release at rat schaffer collateral synapses.NMDA Receptors and Colitis: Basic Science and Clinical Implications.NMDA receptors in the basal ganglia.Facilitation of corticostriatal plasticity by the amygdala requires Ca2+-induced Ca2+ release in the ventral striatum.Neuroprotective effects of Asiaticoside.Signaling cascades regulating NMDA receptor sensitivity to ethanol.NMDA receptor and neonatal hypoxic brain injury.Pregnenolone sulfate and its enantiomer: differential modulation of memory in a spatial discrimination task using forebrain NMDA receptor deficient miceNMDA receptors mediate olfactory learning and memory in Drosophila.Metabotropic glutamate receptors as novel therapeutic targets on visceral sensory pathways.Inflammatory sensitization of nociceptors depends on activation of NMDA receptors in DRG satellite cells.New N-aryl-N'-(3-(substituted)phenyl)-N'-methylguanidines as leads to potential PET radioligands for imaging the open NMDA receptor.Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptorsInhibition by ethanol of NMDA-induced responses and acute tolerance to the inhibition in rat sympathetic preganglionic neurons in vitro and in vivo.Intracisternal administration of NR2 subunit antagonists attenuates the nociceptive behavior and p-p38 MAPK expression produced by compression of the trigeminal nerve root.Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications.The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity.Polyamine metabolism and cancer.Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in miceIncreased Kv1 channel expression may contribute to decreased sIPSC frequency following chronic inhibition of NR2B-containing NMDAR.Expression of the N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunit subtypes in the rat colonAnti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors.Pharmacogenomics: a path to predictive medicine for schizophrenia.
P2860
Q24534164-E1D70E52-725F-467E-ADD3-D51ED57162FCQ24806935-60AB142F-1546-48F0-9C09-1012D02D957AQ27028050-5D405EDA-892E-4CD7-8A92-647D4DCB6218Q27305158-C37E99F8-F552-468F-9450-F64DD95F6746Q28290774-597BCCC4-4EA4-4E31-B673-D7503DD31224Q30011104-64AB9BC5-1FA6-402B-B17E-379CEA75F414Q30175150-5BA592F2-EA47-4849-9843-04BA697D6EC5Q30362017-038128FF-EA75-4C62-9D0B-E640BA1F7FB7Q30386608-212D66E6-F740-4E20-9FF5-0B8CCF29BCF1Q30491310-52B85BBC-7D82-44A6-AAE1-88653D223029Q30491487-92C24285-D6B9-4792-8460-67A75DEDEAD2Q33690565-9D7E8AEB-0E42-4368-8B06-330FC3FDBA70Q33709798-5E8B2570-85E2-4553-A6CA-4FC6BD0E9D8FQ33798598-4E590F02-B75E-4ACF-A4EF-2C7284989926Q33870320-07C2A723-BD8C-4711-B666-3A3BC05B1D35Q33885524-90160C58-D118-4FE5-84A2-DBDC7704ADFEQ33930017-CB481183-C904-4401-A1CA-CFAA854D0290Q33989361-57EB3761-A03B-44FC-8399-2DC3496910F9Q34151559-8FE0E0E9-F44D-4C0D-A901-5190C7576390Q34163165-B6D2EA35-355C-4D05-A9BA-A94F54113D66Q34338197-4E486FDF-C5EA-4301-B34A-0954BAFA35DDQ34469201-653809B2-457B-4009-A107-575B2A56FFEAQ34516771-979ABCB8-F7C4-4F60-B63C-8D0522F54D09Q34609071-36BD6DBE-8E7E-49E1-9FC5-6034303A162DQ34734351-666E45A2-D973-491C-8036-72D3061D4B7AQ34793517-82B10FF1-571F-4A46-8619-55D876C71892Q34949467-7AF213F7-2A3C-4F52-9A82-450C6808BCBDQ35045032-71FDCAEE-3ED2-4234-9B97-517BEC784DD3Q35045842-3EAD2F5A-0F98-4D42-97E8-03C889A41740Q35069330-E850AC2A-B6DE-4E46-9089-C033FD8C0AC3Q35086731-49B11478-38BA-4A2D-9CA2-400C4671F9D3Q35164063-A876F1F8-9AB9-4954-A456-B7D1B6062E03Q35202801-ABD45D4A-DBCF-4B8C-8329-7EF27DE3086BQ35546029-AE62F01B-A50F-450E-950B-F4D90CC63491Q35892703-EC50551D-8E27-48C6-99BF-193983F79FB7Q36102651-C562D650-D1DA-4D8C-B304-07198AFE00BAQ36197690-B9FD70EC-F318-483E-A47E-42008866B662Q36252816-BE4C13F3-EB8F-4426-8C92-62D979597148Q36303035-401609D9-F26E-4700-8CB2-AB2F93581C2FQ36341739-0ED32733-4AE5-42A4-9AC5-A627A3197091
P2860
Subunit- and site-specific pharmacology of the NMDA receptor channel.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Subunit- and site-specific pharmacology of the NMDA receptor channel.
@ast
Subunit- and site-specific pharmacology of the NMDA receptor channel.
@en
type
label
Subunit- and site-specific pharmacology of the NMDA receptor channel.
@ast
Subunit- and site-specific pharmacology of the NMDA receptor channel.
@en
prefLabel
Subunit- and site-specific pharmacology of the NMDA receptor channel.
@ast
Subunit- and site-specific pharmacology of the NMDA receptor channel.
@en
P1476
Subunit- and site-specific pharmacology of the NMDA receptor channel.
@en
P2093
P304
P356
10.1016/S0301-0082(99)00007-6
P577
1999-10-01T00:00:00Z